Prognostic factors affecting survival in malignant pleural mesothelioma: analysis of 125 subjects

Determining the pre-treatment prognostic factors in malignant pleural mesothelioma is important in terms of estimating the course of the disease and selecting patients who are candidate for multimodal therapy. The aim of the study was to determine the prognostic factors affecting survival in patient...

Full description

Saved in:
Bibliographic Details
Published in:Tumori 2014-01, Vol.100 (1), p.55-59
Main Authors: Komurcuoglu, Berna, Cirak, A Kadri, Kirakli, S Cenk, Polat, Gulru, Yucel, Nur, Usluer, Ozan, Erer, Onur, Balci, Gunseli, Gayaf, Mine, Guldaval, Filiz, Aktogu, Serir, Guclu, Salih, Ozsoz, Ayse, Halilcolar, Huseyin
Format: Article
Language:English
Subjects:
Age Factors
Aged
Asbestos - toxicity
Environmental Exposure - adverse effects
Female
Humans
Kaplan-Meier Estimate
Lung Neoplasms - blood
Lung Neoplasms - mortality
Lung Neoplasms - pathology
Lung Neoplasms - therapy
Lymphatic Metastasis
Male
Mesothelioma - blood
Mesothelioma - mortality
Mesothelioma - pathology
Mesothelioma - therapy
Mesothelioma, Malignant
Middle Aged
Neoplasm Staging
Pleural Neoplasms - blood
Pleural Neoplasms - mortality
Pleural Neoplasms - pathology
Pleural Neoplasms - therapy
Prognosis
Retrospective Studies
Risk Factors
Sex Factors
Smoking - adverse effects
Turkey - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Determining the pre-treatment prognostic factors in malignant pleural mesothelioma is important in terms of estimating the course of the disease and selecting patients who are candidate for multimodal therapy. The aim of the study was to determine the prognostic factors affecting survival in patients with malignant pleural mesothelioma. One hundred and twenty-five patients who had been diagnosed histologically as having malignant pleural mesothelioma over the past 5 years were evaluated retrospectively. Relationships of survival of the patients with their age, gender, exposure to asbestos, smoking history, platelet, hemoglobin, leukocyte (WBC) and serum LDH values, histology, performance score and stage of disease were examined. Advanced clinical stage, N2 nodal involvement and the presence of distant metastasis were found to be related to survival. Sarcomatous histology was found to be a poor prognostic factor independently of other factors. We showed that histological subtype and stage of disease were the most important parameters in planning the treatment, especially in determining the patients who were candidate for multimodal treatment and in estimating the prognosis.
ISSN:0300-8916
2038-2529
DOI:10.1177/1430.15816